Extranodal Head and Neck Lymphoma: Prognosis and Patterns of Recurrence

Gary V. Burton, Susan Atwater, Michael J. Borowitz, Andrew T. Huang

Research output: Contribution to journalArticlepeer-review

Abstract

Stages I and II extranodal head and neck lymphomas treated between 1969 and 1986 were reviewed to determine prognosis and recurrence patterns. Forty-four patients had low-grade lymphoma, with 57% remaining disease free (median survival, 7.2 years). Radiotherapy provided long-term disease-free survival and palliation in the majority of patients. Relapse did not adversely affect survival. Eighty-eight patients had intermediate- or high-grade lymphoma, with 42% remaining disease free (median survival, 2.4 years). Treatment with radiotherapy alone was inadequate. Combined radiotherapy and anthracycline-containing chemotherapy appeared to be superior. Extranodal sites of first relapse were common. Central nervous system relapse was common with primary tumors located above the pterygopalatine line. Central nervous system staging and prophylactic therapy is warranted in patients with tumors above the pterygopalatine line. (Arch Otolaryngol Head Neck Surg. 1990;116:69-73)

Original languageEnglish (US)
Pages (from-to)69-73
Number of pages5
JournalArchives of Otolaryngology--Head and Neck Surgery
Volume116
Issue number1
DOIs
StatePublished - Jan 1990
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Extranodal Head and Neck Lymphoma: Prognosis and Patterns of Recurrence'. Together they form a unique fingerprint.

Cite this